<DOC>
	<DOCNO>NCT01406158</DOCNO>
	<brief_summary>A study healthy volunteer compare two different liquid formulation solifenacin tablet formulation .</brief_summary>
	<brief_title>A Study Healthy Volunteers Comparing Two Different Liquid Formulations Solifenacin With Each Other With Tablet Formulation</brief_title>
	<detailed_description>Subjects randomize one six treatment sequence . The treatment separate minimum 13 day dose . Study drug administer overnight fast , food restrict additional four hour dose . Except water provide dosing , water restrict hour hour dosing . Subjects stay study site first three day treatment period . Subjects return study center morning time day Days 4 11 study period pharmacokinetic blood draw vital sign . Subjects study least 40 day .</detailed_description>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<criteria>Subject weigh least 45 kg , body mass index 18 32 kg/m2 Subject normal 12lead electrocardiogram ( ECG ) Subject , female , must least 2 year postmenopausal , surgically sterile , practice effective birth control , pregnant lactating Subject good venous access The subject history clinically significant disease malignancy exception nonmelanoma skin cancer The subject history currently evidence urinary retention , gastric retention , uncontrolled narrowangleglaucoma The subject history unexplained syncope , cardiac arrest , unexplained cardiac arrhythmia torsade de pointes , structural heart disease , family history Long QT syndrome ( suggest sudden death close relative young age due possible probable cardiac cause ) The subject know hypersensitivity VESIcareÂ® excipients formulation , subject history severe allergic anaphylactic reaction The subject history consume 15 unit alcoholic beverage per week , history alcoholism substance abuse within past two year prior screen ( Note : one unit = 12 ounce beer , 4 ounce wine , 1 ounce spirit ) The subject use tobacco contain product nicotine containing product within past six month The subject supine mean systolic blood pressure &lt; 90 &gt; 160 mmHg mean diastolic blood pressure &lt; 50 &gt; 90 mmHg , pulse rate &lt; 40 &gt; 100 beat per minute The subject know positive human immunodeficiency virus antibody The subject positive test hepatitis C antibody hepatitis B antigen The subject 's laboratory test result outside normal limit consider clinically significant The subject treatment prescription nonprescription drug , include complementary alternative medicine overthecounter medication , exception hormonal contraceptive , hormone replacement therapy , occasional use acetaminophen within 14 day prior inclusion study The subject anticipate inability abstain alcohol caffeine use throughout duration study grapefruit , Seville oranges , star fruit , product contain item throughout duration study The subject receive experimental agent within past 30 day ten halflives , whichever long The subject significant blood loss The subject clinically significant history gastrointestinal symptom nausea , abdominal discomfort upset , heartburn four week prior clinic admission , history gastrointestinal surgery except appendectomy cholecystectomy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Solifenacin succinate</keyword>
	<keyword>VESIcare</keyword>
	<keyword>Healthy Volunteers</keyword>
	<keyword>YM905</keyword>
</DOC>